Melissa Carpenter of Canada's Robart Research Institute may have taken herself out of the running for the post of interim head of California's stem cell agency. Then again she may be right at the top of the list.
The London Free Press is reporting, in an article by John Miner, that she is leaving the institute to work for an unnamed biotech firm in San Diego to research the use of stem cells in the treatment of diabetes.
While she may be eager to return to California and start work in her new position, it certainly would not hurt her or her new firm for the good doctor to take a brief leave before actually reporting in San Diego. Spending six months setting up CIRM would provide invaluable experience and contacts for future endeavors.
No comments:
Post a Comment